Alliance Discussion with Dr. Jeffrey Cummings, University of Nevada

More than 6.7 million individuals in the U.S. have Alzheimer’s disease, and that number is growing rapidly. Each day that passes without effective treatments brings tragic consequences for patients and their loved ones. As the debate over coverage for new Alzheimer’s drugs continues,  Jeffrey Cummings, MD, ScD, of the University of Nevada, Las Vegas, joined us to discuss the challenging path that led to these medicines, the state of the science now, and hope for the future. Watch the recording and view his slides.